|
Almeida Capital is pleased to be a premier sponsor of AltAssets
|
FREE newsletter RSS
INTELLIGENCE
RECRUITMENT
KNOWLEDGE BANK
EVENTS
SECTOR ANALYSIS
HEDGE FUNDS
|
PRINT THIS PAGE Warburg Pincus to acquire Bausch & Lomb in $4.5bn transaction16/05/2007. Source: AltAssets. 
 Warburg Pincus has agreed to acquire Rochester, New York-headquartered eye health company Bausch & Lomb in a transaction valued at approximately $4.5bn, including approximately $830m of debt.
Under the terms of the agreement, affiliates of Warburg Pincus will acquire all of the outstanding shares of Bausch & Lomb common stock for $65 per share in cash. This represents a premium of approximately 26 per cent over the volume weighted average price of Bausch & Lomb's shares for the 30 days prior to press reports regarding a potential acquisition of the company, according to a statement.
Bausch & Lomb's board of directors has unanimously approved the agreement and recommends that Bausch & Lomb shareholders approve the merger.
The company's core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The company employs 13,000 people worldwide.
Warburg Pincus currently has approximately $20bn of assets under management.
Copyright © 2007 AltAssets
|
 
|
|
|
